Abstract 12863: Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis of Mortality and Major Thromboembolic Events in 16,496 Patients From the MAGELLAN and MARINER Trials

Gary E. Raskob,Alex C. Spyropoulos,Alexander T. Cohen,Theodore E. Spiro,Wentao Lu,Bennett Levitan,Eun-Young Suh,Elliot S. Barnathan

Abstract 12863: Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis of Mortality and Major Thromboembolic Events in 16,496 Patients From the MAGELLAN and MARINER Trials

2019

Gary E. Raskob
Alex C. Spyropoulos
Alexander T. Cohen
Theodore E. Spiro
Wentao Lu
Bennett Levitan
Eun-Young Suh
Elliot S. Barnathan

Introduction: Thromboprophylaxis extended after hospital discharge in high- risk medical patients remains controversial due to uncertainty about the benefit for preventing fatal or major thromboemb...

Keywords:

Diabetes mellitus
hospital discharge
Emergency medicine
Rivaroxaban
Clinical trial
pooled analysis
Thrombosis
Internal medicine
Medicine
Cardiology
medical illness

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations